Pictet Asset Management
ABUS icon

Pictet Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Pictet Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Hold
23,927
– – ﹤0.01% 2078
2026
Q1 		$108K Hold
23,927
– – ﹤0.01% 2029
2025
Q4 		$115K Hold
23,927
– – ﹤0.01% 2008
2025
Q3 		$109K Hold
23,927
– – ﹤0.01% 1972
2025
Q2 		$73.9K Hold
23,927
– – ﹤0.01% 1971
2025
Q1 		$83.5K Buy
23,927
+11,007
+85% +$36.7K ﹤0.01% 1955
2024
Q4 		$42.2K Hold
12,920
– – ﹤0.01% 2029
2024
Q3 		$49.7K Buy
+12,920
New +$49.6K ﹤0.01% 1997

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Pictet Asset Management's ABUS Position: Q2 2026 in Review

Pictet Asset Management held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 23,927 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

Pictet Asset Management first reported a position in ABUS in Q3 2024 and has held it in 8 quarters since. The position peaked at $115K in Q4 2025. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Pictet Asset Management held 23,927 shares of Arbutus Biopharma worth $115K as of Q2 2026.
  • Pictet Asset Management left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2078 holding.
  • Pictet Asset Management first reported a position in Arbutus Biopharma in Q3 2024 and has held it in 8 quarters since.
  • Pictet Asset Management's Arbutus Biopharma position peaked at $115K in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.